The past 2 years have seen major breakthroughs in endovascular treatment for acute ischaemic stroke. As highlighted in 2016, we now need to refine the logistics for delivery of this treatment, including patient selection. We should not forget, however, that it is better to prevent strokes in the first place.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
Journal of Neuroinflammation Open Access 07 June 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723–1731 (2016).
Saver, J. L. et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316, 1279–1288 (2016).
Lima, F. O. et al. Field assessment stroke triage for emergency destination: a simple and accurate prehospital scale to detect large vessel occlusion strokes. Stroke 47, 1997–2002 (2016).
Amarenco, P. et al. One-year risk of stroke after transient ischemic attack or minor stroke. N. Engl. J. Med. 374, 1533–1542 (2016).
Rothwell, P. M. et al. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 388, 365–375 (2016).
Wang, Y. et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N. Engl. J. Med. 369, 11–19 (2013).
Wang, Y. et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316, 70–78 (2016).
O'Donnell, M. J. et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case–control study. Lancet 388, 761–775 (2016).
Feigin, V. L. et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 15, 913–924 (2016).
World Stroke Organisation. Campaign Resources Toolkit 2016. WorldStrokeCampaign http://www.worldstrokecampaign.org/get-involved/campaign-toolkit-2016.html (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Algra, A., Wermer, M. Stroke is treatable, but prevention is the key. Nat Rev Neurol 13, 78–79 (2017). https://doi.org/10.1038/nrneurol.2017.4
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2017.4
This article is cited by
-
Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies
Journal of Neurology (2021)
-
ClC-3 induction protects against cerebral ischemia/reperfusion injury through promoting Beclin1/Vps34-mediated autophagy
Human Cell (2020)
-
NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
Journal of Neuroinflammation (2019)